Action JUNIPER PHARMACEUTICALS INC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Juniper Pharmaceuticals Inc

Actions

US48203L1070

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Juniper Pharmaceuticals : Reports Second Quarter 2018 Financial and Operating Results
PR
Juniper Pharmaceuticals : Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash
PR
Juniper Pharmaceuticals : Reports First Quarter 2018 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report First Quarter 2018 Results on May 10, 2018
PR
Juniper Pharmaceuticals : Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
PR
Juniper Pharmaceuticals : Appoints Richard Messina to Board of Directors
PR
Juniper Pharmaceuticals : Reports Full-Year 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018
PR
Juniper Pharmaceuticals : to Explore Strategic Alternatives
PR
Juniper Pharmaceuticals : Announces 4.5-Year Extension through 2024 of CRINONE® Supply Agreement with Merck KGaA, Darmstadt, Germany
PR
Juniper Pharmaceuticals : Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress
PR
Juniper Pharmaceuticals : Reports Third Quarter 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report Third Quarter 2017 Results on November 2, 2017
PR
Juniper Pharmaceuticals : Announces Strategic Reprioritization
PR
Juniper Pharmaceuticals : Appoints Jennifer Good to Board of Directors
PR
Juniper Pharmaceuticals : Reports Second Quarter 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report Second Quarter 2017 Results on August 3, 2017
PR
Juniper Pharmaceuticals : Announces Results of 2017 Annual Meeting
PR
Juniper Pharmaceuticals : Reports First Quarter 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report First Quarter 2017 Results on May 4, 2017
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action
  4. Actualités Juniper Pharmaceuticals Inc
  5. Communiqués